Liprolog Mix25 Kwikpen (Insulin Lispro)

Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.

• Type 1 diabetes mellitus: improves post‑prandial glucose control and reduces hyperglycaemic episodes.
• Type 2 diabetes mellitus: assists in achieving glycaemic targets when combined with oral agents or basal insulin.
• Gestational diabetes mellitus: provides rapid insulin coverage when diet and oral agents are insufficient.

• Insulin lispro binds to insulin receptors on muscle and adipose cells, activating the receptor’s tyrosine kinase activity. This stimulates glucose transporter (GLUT4) translocation to the cell membrane, enhancing glucose uptake and utilization. It also suppresses hepatic gluconeogenesis, leading to a rapid reduction in circulating blood glucose levels after injection.

Common Side Effects

• Hypoglycaemia: low blood glucose episodes, especially if meals are missed or delayed.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Weight gain: modest increase due to improved glucose utilisation.
• Lipodystrophy: localized changes in subcutaneous fat with repeated injections.
• Localised allergic reactions: rash or urticaria at the site.
• Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects

• Severe hypoglycaemia leading to seizures or loss of consciousness.
• Anaphylactic reaction: difficulty breathing, swelling of face or throat.
• Severe allergic reaction: widespread rash, hives, or angioedema.
• Edema: abnormal fluid retention, particularly in the lower extremities.
• Hypokalemia: low potassium levels, potentially causing cardiac arrhythmias.
• Acute insulin allergy: systemic symptoms requiring immediate medical attention.

Before using Liprolog Mix25 Kwikpen, consider the following precautions:

• Hypoglycaemia risk: monitor blood glucose closely and adjust meals or activity.
• Dose adjustments: modify insulin dose when changing diet, exercise, or during illness.
• Renal or hepatic impairment: use lower initial doses and monitor response.
• Pregnancy and lactation: evaluate benefit‑risk ratio with a healthcare professional.
• Allergic reactions: discontinue if signs of systemic hypersensitivity appear.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro may interact with several medicines that affect glucose levels.

Major Interactions (Avoid)

• Sulfonylureas: additive hypoglycaemic effect.
• Meglitinides: increased risk of severe hypoglycaemia.
• Beta‑blockers: may mask hypoglycaemia symptoms.
• Glucocorticoids: raise blood glucose, requiring dose increase.
• Alcohol: potentiates hypoglycaemia, especially with fasting.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors: may enhance insulin sensitivity, requiring dose review.

• Thiazide diuretics: can increase blood glucose levels.
• Antipsychotics: may cause weight gain and hyperglycaemia.
• NSAIDs: affect renal function, influencing insulin clearance.
• Thyroid hormones: alter metabolic rate, potentially affecting glucose control.